封閉蛋白3(CLDN3)重組蛋白
Recombinant Claudin 3 (CLDN3)
C7orf1; CPE-R2; CPETR2; HRVP1; RVP1; Clostridium Perfringens Enterotoxin Receptor 2; Ventral Prostate.1-Like Protein; CPE-Receptor 2
- 編號RPF293Mu01
- 物種Mus musculus (Mouse，小鼠)相同的名稱，不同的物種。
- 來源原核表達
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位細胞膜
- 預測分子量-
- 實際分子量-(差異分析請參閱說明書)
- 片段與標簽N-terminal His Tag
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液（pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300）
- 性狀凍干粉
- 純度> 95%
- 等電點-
- 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載英文說明書 中文說明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價格¥ 1051¥ 2628¥ 5256¥ 15768¥ 39420
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
Figure. SDS-PAGE
通過ISO 9001、ISO 13485質(zhì)量體系認證
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPF293Mu01 | 封閉蛋白3(CLDN3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPF293Mu02 | 封閉蛋白3(CLDN3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAF293Mu01 | 封閉蛋白3(CLDN3)多克隆抗體 | WB; IHC; ICC; IP. |
| PAF293Mu02 | 封閉蛋白3(CLDN3)多克隆抗體 | WB; IHC; ICC; IP. |
| LAF293Mu71 | 封閉蛋白3(CLDN3)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| SEF293Mu | 封閉蛋白3(CLDN3)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMF293Mu | 封閉蛋白3(CLDN3)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Eur J Appl Physiol | Gastrointestinal response and endotoxemia during intense exercise in hot and cool environments[Pubmed: 23314685] |
| European Journal of Applied Physiology | Effects of probiotics supplementation on gastrointestinal permeability, inflammation and exercise performance in the heat[Springer: Source] |
| Pediatr Crit Care Med | Clinical Characteristics Associated With Postoperative Intestinal Epithelial Barrier Dysfunction in Children With Congenital Heart Disease*[PubMed: 25162512] |
| Clinical Nutrition | Reinforcement of intestinal epithelial barrier by arabinoxylans in overweight and obese subjects: A randomized controlled trial: Arabinoxylans in gut barrier.[pubmed:28214040] |
| Clinics and Research in Hepatology and Gastroenterology | Plasma claudin-3 is associated with tumor necrosis factor-alpha-induced intestinal endotoxemia in liver disease[Pubmed: 31053499] |
| Nutrients | Intestinal Permeability in Children with Celiac Disease after the Administration of Oligofructose-Enriched Inulin into a Gluten-Free Diet—Results of a Randomized …[Pubmed: 32531982] |
| Journal of Exercise Physiology Online | Markers of Intestinal Damage in Individuals with and without Obesity during a 12-Week Exercise Period.[] |
| JACC: Basic to Translational Science | Dysbiosis and Intestinal Barrier Dysfunction in Pediatric Congenital Heart Disease is Exacerbated Following Cardiopulmonary Bypass[] |
| Nutrients | Short-Term Very High Carbohydrate Diet and Gut-Training Have Minor Effects on Gastrointestinal Status and Performance in Highly Trained Endurance Athletes[Pubmed:35565896] |